comparemela.com

Latest Breaking News On - Jean claude mongrenier - Page 1 : comparemela.com

Biolog-id and Genesis Growth Tech Acquisition Corp

Anticipated Cash Resources to be used to Advance Biolog-id Value Chain Optimization Platform for Blood Products and other Biologics.

United statesÎe de franceUnited arab emiratesDiane mullerCarey olsenAsia pacificSteven halperTroyl hilsenrothEyal perezJean claude mongrenierCharles russell speechlysOmelveny myersGenesis growth tech acquisition corporationGenesis growth tech acquisition corpExchange commissionAllen overy

Xerys Funds Inject an Additional $25 Million of New Capital into Biolog-id

Investment to Accelerate On-Going Expansion of Global Commercial FootprintPARIS, May 05, 2022 (GLOBE NEWSWIRE) Xerys Invest, a private equity firm focused on Healthcare, Life Sciences, Renewable Energy

France generalOlivier ossipoffAnna adlewskaKostenloser wertpapierhandelDiane mullerAsia pacificTroyl hilsenrothJean claude mongrenierRenewable energyHealth life sciencesLife sciencesAccelerate on going expansionGlobal commercialXerys investXerys fundsMiddle east

Investegate |Biolog-id Announcements | Biolog-id: Xerys Funds Inject an Additional $25 Million of New Capital into Biolog-id

Investegate announcements from Biolog-id, Xerys Funds Inject an Additional $25 Million of New Capital into Biolog-id

France generalOlivier ossipoffAnna adlewskaDiane mullerAsia pacificTroyl hilsenrothJean claude mongrenierRenewable energyHealth life sciencesLife sciencesXerys funds injectNew capitalAccelerate on going expansionGlobal commercialXerys investXerys funds

Dominik Belloin Joins biolog-id s Board of Directors

Biolog-id, a global leader in the traceability of sensitive therapeutic products, has just co-opted Dominik BELLOIN within the company's board. He will sit alongside Pierre Lesourd, Jean-Louis Colders

New yorkUnited statesCity ofUnited kingdomJean louis coldersDominik belloinJacques simonnetKostenloser wertpapierhandelAstrid billardAsia pacificPierre lesourdJean claude mongrenierHarvard business schoolMerrill lynchCommittee of the oddo cie groupLife sciences

vimarsana © 2020. All Rights Reserved.